Information
-
Trademark
-
86480624
-
Serial Number
86480624
-
Registration Number
5171990
-
International Classifications
-
Filing Date
December 15, 2014
10 years ago
-
Registration Date
March 28, 2017
7 years ago
-
Transaction Date
November 21, 2023
a year ago
-
Status Date
October 13, 2023
a year ago
-
Published for Opposition Date
June 07, 2016
8 years ago
-
Location Date
February 21, 2017
7 years ago
-
First Use Anywhere Date
May 10, 2016
8 years ago
-
First Use In Commerce Date
May 10, 2016
8 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
PEREZ, STEVEN M
-
Attorney Docket Number
ACIP0124
Attorney Name
Timothy T. Wang
Law Office Assigned Location Code
L10
-
Owners
Mark Drawing Code
5000
Mark Identification
HAMPLATIN
Case File Statements
- DM0000: The mark consists of the term "HAMPLATIN" in stylized font.
- GS0051: Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes
- CC0000: Color is not claimed as a feature of the mark.
- GS0421: Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design
Case File Event Statements
-
10/13/2023 - a year ago
30 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
3/28/2022 - 2 years ago
29 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
3/28/2017 - 7 years ago
28 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
2/22/2017 - 7 years ago
27 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
2/21/2017 - 7 years ago
26 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
2/15/2017 - 7 years ago
25 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
1/25/2017 - 8 years ago
24 - USE AMENDMENT FILED
Type: IUAF
-
2/11/2017 - 7 years ago
23 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
1/25/2017 - 8 years ago
22 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
8/2/2016 - 8 years ago
21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/7/2016 - 8 years ago
20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/7/2016 - 8 years ago
19 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/18/2016 - 8 years ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/29/2016 - 8 years ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/26/2016 - 8 years ago
16 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/25/2016 - 8 years ago
15 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/25/2016 - 8 years ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
10/27/2015 - 9 years ago
13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
10/27/2015 - 9 years ago
12 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
10/27/2015 - 9 years ago
11 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
9/29/2015 - 9 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/28/2015 - 9 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/28/2015 - 9 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/28/2015 - 9 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
3/28/2015 - 9 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/28/2015 - 9 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/26/2015 - 9 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/4/2015 - 9 years ago
3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
12/19/2014 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
12/18/2014 - 10 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP